EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Multi‐Center, Real‐World Registry Study of the UroLift Prostatic Urethral Lift ( PUL ) for Benign Prostatic Hyperplasia ( BPH ) in Japan

Naoya Masumori iD, Satoru Takahashi, Go Anan, Fumiyasu Endo iD, Akira Furuta iD, Kazunori Haga iD, Mina Hatanaka, Shinobu Kato, Yoshihiro Komai, Yuki Kyoda, Nayuka Matsuyama, Shinichiro Murayama und 4 weitere

International Journal of Urology · 2026-06 · 33 (6)

DOI: 10.1111/iju.70529 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, online erschienen am 15.06.2026. Verfasst von Naoya Masumori und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sapporo Medical University, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Urethra, Lower Urinary Tract Symptoms. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH) has been shown to deliver rapid, durable symptom relief with low morbidity. Most studies have been performed in Western populations. The objective was to understand how PUL performs in the real world in Japan among a broad patient population.

Methods

A post‐market registry study of consecutive PUL subjects across 14 Japanese centers was conducted. International Prostate Symptom Score (IPSS), quality of life (QOL), maximum flow rate ( Q max ) and sexual function were evaluated at baseline, 3‐ and 12‐ months post‐procedure. Paired t ‐tests compared baseline and follow‐up data. Subject demographics, adverse events, BPH medication use, catheterization, and surgical retreatment were reported.

Results

210 subjects were included. Baseline characteristics included age 74.3 ± 8.5 years, IPSS 18.0 ± 7.4, QOL 4.8 ± 1.3, Q max 10.3 ± 5.5 mL/s and prostate volume 40.5 ± 16.1 cc. Paired analyses indicated IPSS improved 6.6 (36.9%), p < 0.0001; QOL improved 2.1 (43.3%), p < 0.0001 and Q max improved 1.5 (14.7%) mL/s ( p = 0.023) at 12 months. Sexual function measures were unchanged or significantly improved, although results should be interpreted with caution due to a high degree of missing data. BPH medication use decreased from 76.7% to 12.4%; One subject was surgically retreated by 12 months. Adverse events were typically mild–moderate and transient.

Conclusions

This registry study from Japan indicates PUL is safe and effective; results corroborate those of previous studies. The data support the use of PUL in the broader BPH population in Japan. Trial Registration Japan Registry of Clinical Trials (jRCT 2032220377)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaUrethraLower Urinary Tract SymptomsHumansMaleJapanRegistriesAgedQuality of LifeAged, 80 and overTreatment OutcomeProstateMiddle AgedProduct Surveillance, Postmarketing

Stichwörter der Autor:innen

Japanbenign prostatic hyperplasialower urinary tract symptomsminimally invasive surgeryreal world clinical trials

Autor:innen und Institutionen

  • Department of Urology, Sapporo Medical University, Sapporo, Hokkaido, Japan.
  • Department of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
  • Department of Urology, Yotsuya Medical Cube, Chiyoda-ku, Tokyo, Japan.
  • Department of Urology, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
  • Department of Urology, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Department of Urology, Sanjukai Urological Hospital, Sapporo-shi, Hokkaido, Japan.

ORCID-Profile: Naoya Masumori, Fumiyasu Endo, Akira Furuta, Kazunori Haga, Daisuke Obinata

Zitieren

APA

Masumori, N., Takahashi, S., Anan, G., Endo, F., Furuta, A., Haga, K., Hatanaka, M., Kato, S., Komai, Y., Kyoda, Y., Matsuyama, N., Murayama, S., Nagamatsu, H., Obinata, D., Sekiguchi, Z., & Waseda, Y. (2026). Multi‐Center, Real‐World Registry Study of the UroLift Prostatic Urethral Lift ( PUL ) for Benign Prostatic Hyperplasia ( BPH ) in Japan. International Journal of Urology, 33(6). https://doi.org/10.1111/iju.70529

Vancouver

Masumori N, Takahashi S, Anan G, Endo F, Furuta A, Haga K, et al. Multi‐Center, Real‐World Registry Study of the UroLift Prostatic Urethral Lift ( PUL ) for Benign Prostatic Hyperplasia ( BPH ) in Japan. International Journal of Urology. 2026;33(6). doi:10.1111/iju.70529

BibTeX
@article{Masumori2026,
  author = {Masumori, Naoya and Takahashi, Satoru and Anan, Go and Endo, Fumiyasu and Furuta, Akira and Haga, Kazunori and Hatanaka, Mina and Kato, Shinobu and Komai, Yoshihiro and Kyoda, Yuki and Matsuyama, Nayuka and Murayama, Shinichiro and Nagamatsu, Hirotaka and Obinata, Daisuke and Sekiguchi, Zenkichi and Waseda, Yuma},
  title = {Multi‐Center, Real‐World Registry Study of the UroLift Prostatic Urethral Lift ( PUL ) for Benign Prostatic Hyperplasia ( BPH ) in Japan},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {6},
  doi = {10.1111/iju.70529}
}
Kostenlos starten →